Merck Income from Continuous Operations 2010-2024 | MRK

Merck income from continuous operations for the twelve months ending December 31, 2024 was $17.133B, a 4444.56% increase year-over-year.

  • Merck annual income from continuous operations for 2024 was $17.133B, a 4444.56% increase from 2023.
  • Merck annual income from continuous operations for 2023 was $0.377B, a 97.4% decline from 2022.
  • Merck annual income from continuous operations for 2022 was $14.526B, a 17.54% increase from 2021.

Merck Income from Continuous Operations 2010-2024 | MRK

  • Merck annual income from continuous operations for 2024 was $17.133B, a 4444.56% increase from 2023.
  • Merck annual income from continuous operations for 2023 was $0.377B, a 97.4% decline from 2022.
  • Merck annual income from continuous operations for 2022 was $14.526B, a 17.54% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Pfizer (PFE)$146.7B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B